But a study by Canadian scientists published in Jama Ophthalmology has found that after six months of use GLP-1 RAs are associated with double the risk of older people with diabetes developing neovascular age-related macular degeneration compared with similar patients not taking the drugs
Similarly, the FDA has approved a number of injectable GLP-1s for type 2 diabetes, such as Ozempic (semaglutide), Mounjaro (tirzepatide), and (semaglutide), an oral GLP-1 medication for blood sugar control in people with type 2 diabetes
With weight loss pills now coming to market, the number of people caught up in various GLP-1 ripple effects is only going to increase
Another Harvard-led study found a 29% increase in coronary heart disease risk for each 0.5-point increase in HbA1c above 5.0%. In practical terms, continued Dr
Key Benefits of Aqua Skin Pure Gold II 30th Whitening Injection Intensive Skin Whitening & Spot Reduction It reduces melanin production